PC

Philip Cohen

Advisor at MISSION Therapeutics

For 45 years, Prof. Cohen has studied protein phosphorylation in cell regulation and human disease, and has made multiple major contributions to the field. He is now working to unravel signaling networks within the innate immune system involving protein ubiquitylation and phosphorylation during bacterial and viral infections. Prof Cohen is also involved in commercial activities based in Dundee and is frequently cited as the magnet for academics and biotechnology companies and economic regeneration in the city, as 15% of the Dundee economy derives from biotech and its employees.

Timeline

  • Advisor

    Current role